-- Consolidated Net Sales Increased 21% YoY to $66.7 Million; International
Export Sales Increased 758%
-- Consolidated Net Income from Continuing Ops of $10.8 Million or $0.09 Per
Share, Up YoY and Sequentially
-- Consolidated Adjusted EBITDA of $20.2 Million or 30.3% of Sales; Both
Company Records
-- Operating Cash Flow of $24.4 Million Brings YTD Total to $46.7 Million;
Company Ends Quarter with Approximately $88 Million in Cash
-- Canadian Cannabis Delivers Record Net Sales, Record Gross Margin of 56%,
Record Adj. EBITDA and Record Cash Flow from Operations; 40 Metric Ton
Production Capacity Expansion Underway
-- Continued Momentum in Netherlands Cannabis Sales as Capacity Expansion
Progresses on Schedule
VANCOUVER, British Columbia, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Village Farms International, Inc. ("Village Farms" or the "Company") (NASDAQ: VFF) today reported financial results for its third quarter ended September 30, 2025. All figures are in U.S. dollars unless otherwise indicated.
Management Commentary
"The Company delivered another quarter of record financial performance that demonstrates our continued success profitably scaling what we believe is one of the most attractive platforms for value creation in the global cannabis industry," said Founder, President and Chief Executive Officer Michael DeGiglio. "Our team achieved several new performance records in Q3, with both year-over-year and sequential increases in each of net income from continuing operations, adjusted EBITDA and cash flow from operations. Congratulations to all our Village Farms team members around the world whose hard work, tenacity and integrity are continuing to enable our success."
"In Canada, our recent efforts to align our product portfolio toward higher margin SKUs is driving sales growth in targeted channels and, along with our expanding international export sales, we delivered 29% year-over-year growth in net sales, record gross margin of 56%, a 900% year-over-year increase in net income, a 306% increase in adjusted EBITDA and a 331% increase in cash flow from operations. Our previously announced 40 metric ton capacity expansion project is now underway and will ramp through 2026, supporting further growth in our Canadian and international export markets with the consistent supply of quality cannabis products the world expects from Village Farms."
"In the Netherlands, we experienced continued momentum in sales growth during the third quarter and our Drachten facility has now reached its full operating capacity. Our team has continued to improve our portfolio of product offerings to coffeeshops as well as our overall market penetration, and we remain very pleased with our competitive position in the Dutch market. Construction of our second and larger Dutch facility, which will expand production capacity five-fold, is progressing on plan and remains on schedule to be operational during the first quarter of next year. Once complete, we expect this facility to enable us to drive further improvements in revenue growth and cash flow generation for the Company."
"Our strong third quarter performance also drove another quarter of continued healthy cash flows from operations of $24.4 million, bringing our total cash position at quarter end to $87.6 million. Our significantly improved cash flow generation profile and balance sheet will enable us to continue expansion projects and possible strategic investments, and gave our Board of Directors confidence to initiate a share repurchase program at the end of the third quarter as part of a balanced approach to capital allocation to drive returns to shareholders."
"Looking ahead, we remain highly motivated to exceed our own expectations and are confident in our ability to continue driving profitable sales growth and strong cash flow generation. With capacity expansion projects in Europe and Canada coming online next year, along with the strength of our balance sheet and our focus on continuous improvement, we see a very bright future for Village Farms as we continue executing our growth strategy and pursuing various expansion opportunities around the world."
Third Quarter 2025 Financial Highlights
(All comparable periods are for the third quarter of 2024 unless otherwise stated)
Consolidated
-- Consolidated net sales increased 21% to $66.7 million from $54.9 million;
-- Consolidated net income from continuing operations was $10.8 million, or
$0.09 per share compared with a net loss of $0.8 million, or ($0.01) per
share;
-- Consolidated cash flow from operations was $24.4 million compared with
$6.5 in the prior year period;
-- YTD consolidated cash flow from operations was $46.7 million compared
with $2.8 million; and,
-- Consolidated adjusted EBITDA from continuing operations (a non-GAAP
measure) was $20.7 million or 31.0% of sales, compared with $4.7 million
or 8.5% of sales in the prior year period.
Canadian Cannabis
-- Net sales increased 29% to $46.6 million (C$64.1 million) from $36.5
million (C$49.8 million);
-- International medical export sales increased 758%; retail branded sales
decreased 4% due to a planned mix shift toward higher-margin products;
-- Gross margin increased to 56% from 26%, driven by improvements in
operating efficiency leading to lower costs of production and an
increased mix of higher-margin international export sales;
-- Net income increased 900% to $11.7 million (C$16.0 million) from $1.2
million (C$1.6 million);
-- Adjusted EBITDA increased 306% to $19.3 million (C$26.6 million) from
$4.8 million (C$6.5 million); and,
-- Cash flow from operations increased 331% to $19.4 million (C$26.8
million) from $4.5 million (C$6.1 million).
U.S. Cannabis (Balanced Health Botanicals)
-- Net sales were $3.3 million compared with $3.9 million; -- Gross margin decreased to 60% from 63%; -- Net loss was $0.4 million compared with a net loss of $0.2 million; and -- Adjusted EBITDA was ($0.3 million) compared with ($0.2 million).
Netherlands Cannabis (Leli Holland)
Leli Holland was non-operational during the comparable quarter of 2024. As a result, comparative financial performance to the prior-year quarter is not meaningful.
-- Net sales were $3.6 million; -- Net income was $0.8 million; and -- Adjusted EBITDA was $1.3 million.
Village Farms Produce
-- Sales from continuing operations of $12.8 million were essentially flat
as compared to the prior year as 2025 sales has a commission to Vanguard
Food, L.P.;
-- Net income from continuing operations improved to $1.3 million compared
to $0.3 million; and,
-- Adjusted EBITDA from continuing operations improved to $2.5 million from
$1.7 million.
Strategic Growth and Operational Highlights
Canadian Cannabis
-- Company continues to maintain a top five overall market share position in
Canada and the number two position in dried flower despite planned
reductions in sales of lower-margin SKUs1;
-- Significantly surpassed the high end of its targeted gross margin range
of 30-40%, marking the third consecutive quarter meeting or exceeding the
target range, contributing to record quarterly and YTD adjusted EBITDA
performance;
-- Introduced several new and unique packaging innovations to the Canadian
market, including the launch of a one-way aroma valve built directly into
its dried flower packaging, windowed packaging for its flower products
which enables consumers to see product before purchase, and a proprietary
built-in matchbox accessory for its pre-roll offerings to meet growing
demand for ready-to-enjoy cannabis experiences;
-- Published groundbreaking peer-reviewed research in Scientific Reports
(Nature Portfolio), highlighting the natural variability of THC potency
within cannabis plants, reinforcing a need for a greater focus on product
quality versus potency and more transparent and accurate labelling across
the industry; and,
-- Subsequent to quarter end, began expansion of cultivation capacity in its
Delta 2 greenhouse to meet increasing demand in Canadian and
international export markets. The expansion is being funded with existing
cash on hand and is expected to yield an incremental 40 metric tons of
annualized cannabis production, expanding capacity by approximately 33%.
1. Based on estimated retail sales from HiFyre, other third parties and
provincial boards
International Cannabis (Reported within Canadian Cannabis)
-- International export sales increased 758% year-over-year, driven by
continued strength of demand in Germany and steady performance across
other international markets;
-- Company believes that it remains the largest exporter of medical cannabis
to Europe, and that it has gained market share sequentially in Germany in
each of the past four quarters1
-- Company continues to distribute several leading cultivars in Germany and
other international medical markets through third-party partners2; and
-- Company anticipates entering additional international medical markets
during the first half of calendar year 2026.
1. Based on German government data and Company estimates
2. Based on Company estimates and ranking compiled by German outlet Flowzz
Netherlands Cannabis (Leli Holland)
-- Operations in the Company's Phase I facility in Drachten have now ramped
to full capacity while demonstrating strong profitability and cash flow
generation;
-- Leli Holland products are now represented in 91% of participating
coffeeshops, representing increased market penetration sequentially as
compared to the second quarter;
-- The Company has continued to introduce new products into the market,
including hash offerings and pre-rolls and it expects to launch
additional products for coffeeshops during the fourth quarter;
-- Construction of the Company's Phase II facility in Groningen remains on
track to be operational in Q1 2026. When completed, the Phase II facility
is expected to quintuple total annualized production capacity to
approximately 10,000 kilograms.
U.S. Cannabis
-- The Company's application for a Texas medicinal marijuana license remains
pending review by the Department of Public Services. New license awards
are expected to be granted on December 1, 2025. If awarded, the Company
plans to work with its listing authority to structure an acceptable
ownership structure and comply with all applicable regulatory
requirements.
Corporate
-- On September 29, 2025, the Company's Board of Directors unanimously
approved a US$10 million share repurchase authorization for up to
5,687,000 common shares (five percent of the Company's issued and
outstanding common shares at the date of announcement).
-- On November 6, 2025, the Company announced the hiring of Brian Ellis to
the role of Chief Information and Technology Officer (CITO) to lead the
Company's global technology and information strategy. Mr. Ellis brings
over 25 years of enterprise architecture, IT strategy, and large-scale
digital transformation experience across various global industries,
including roles at Nike, Topgolf Callaway, and Booking.com.
Conference Call
Village Farms' management team will host a conference call to discuss its third quarter 2025 financial results today, Monday, November 10, 2025, at 8:30 a.m. ET. Participants can access the conference call via a webcast at Village Farms Third Quarter 2025 Conference Call Webcast or on the company website at Village Farms - Events. Participants wanting to access the conference call by telephone must register in advance at Village Farms Third Quarter 2025 Conference Call Registration to receive telephone dial-in information.
The live question and answer session will be limited to analysts; however, others are invited to submit questions ahead of the conference call via email at investorrelations@villagefarms.com. Management will address questions received via email during the question-and-answer session as time permits.
About Village Farms International, Inc.
Village Farms leverages decades of experience in Controlled Environment Agriculture as a large-scale, vertically-integrated supplier of high-value, high-growth plant-based Consumer Packaged Goods. The Company built a strong foundation as the leading and longest-tenured fresh produce supplier to grocery and large-format retailers throughout the US and Canada, but now focuses its agricultural expertise on high-growth cannabinoid opportunities internationally while maintaining strategic optionality through remaining produce assets.
In Canada, the Company's wholly owned Canadian subsidiary, Pure Sunfarms, is one of the single largest cannabis operations in the world (2.2 million square feet of greenhouse production), a low-cost producer and one of Canada's highest quality and best-selling brands. The Company owns an incremental 2.6 million square feet of greenhouse capacity in Canada for future expansion, and also owns 80% of Québec-based, Rose LifeScience, a leader in the commercialization of cannabis products.
Internationally, Village Farms is targeting selected, nascent, legal cannabis opportunities with significant growth potential. The Company exports medical cannabis from its EU GMP certified facility in Canada to international markets including Germany, the United Kingdom, Israel, Australia, and New Zealand. The Company is expanding its export business to new countries and customers, and making select investments in international production assets. In Europe, wholly-owned Leli Holland has one of 10 licenses to grow and distribute recreational cannabis within the Dutch Coffee Shop Experiment.
In the US, wholly-owned Balanced Health Botanicals is one of the leading CBD and hemp-derived brands and e-commerce platforms in the country. Subject to compliance with all applicable US federal and state laws and stock exchange rules, Village Farms plans to enter the US THC market via multiple strategies, leveraging its Texas-based greenhouse assets (2.2 million square feet of existing greenhouse capacity and 950 acres of owned, unoccupied land for future expansion).
Village Farms Clean Energy (VFCE), through a partnership with Atlanta-based Terreva Renewables, creates renewable natural gas from landfill gas at its Delta RNG facility. VFCE receives royalties on all revenue generated.
Contact Information
Sam Gibbons
Senior Vice President, Corporate Affairs
Phone: (407) 936-1190 ext. 328
Email: sgibbons@villagefarms.com
Lawrence Chamberlain
LodeRock Advisors
Phone: (416) 519-4196
Email: lawrence.chamberlain@loderockadvisors.com
Canadian Cannabis Performance Summary
(millions except Three Months Ended September
% metrics) 30,
------------------------------
2025 2024
-------------- --------------
Change
CAD $ USD $ CAD $ USD $ of C $
------ ------ ------ ------ --------
Total Net Sales $ 64.1 $ 46.6 $ 49.8 $ 36.5 29%
Total Cost of
Sales $ 28.3 $ 20.6 $ 36.7 $ 26.9 -23%
Gross Profit $ 35.8 $ 26.0 $ 13.1 $ 9.6 173%
Gross Margin % 56% 56% 26% 26% 112%
SG&A $ 12.8 $ 9.1 $ 10.9 $ 8.0 17%
Net income $ 16.0 $ 11.7 $ 1.6 $ 1.2 900%
Adjusted EBITDA
(1) $ 26.6 $ 19.3 $ 6.5 $ 4.8 309%
Adjusted EBITDA
Margin (1) 41% 41% 13% 13% 218%
Cash flow from
Operations $ 26.8 $ 19.4 $ 6.1 $ 4.5 339%
(millions except Nine Months Ended September
% metrics) 30,
------------------------------
2025 2024
-------------- --------------
Change
CAD $ USD $ CAD $ USD $ of C $
------ ------ ------ ------ --------
Total Net Sales $175.5 $125.9 $156.0 $114.7 13%
Total Cost of
Sales $ 97.7 $ 70.0 $115.4 $ 84.8 -15%
Gross Profit $ 77.8 $ 55.9 $ 40.6 $ 29.9 92%
Gross Margin % 44% 44% 26% 26% 70%
SG&A $ 37.1 $ 26.5 $ 33.3 $ 24.4 11%
Net income $ 29.5 $ 21.2 $ 4.6 $ 3.4 541%
Adjusted EBITDA
(1) $ 52.7 $ 37.9 $ 18.6 $ 13.6 183%
Adjusted EBITDA
Margin (1) 30% 30% 12% 12% 152%
Cash flow from
Operations $ 56.0 $ 40.6 $ 19.4 $ 14.3 189%
Canadian Cannabis' Composition of Sales by Channel
(millions except
% metrics) Three Months Ended September 30,
---------------------------------
2025 2024
--------------- ---------------
Change of
CAD $ USD $ CAD $ USD $ C $
------ ------ ------ ------ ----------
Retail Branded
Sales $ 58.6 $ 42.5 $ 61.3 $ 44.9 -4%
Non-Branded Sales $ 10.1 $ 7.3 $ 10.1 $ 7.4 0%
International
Sales $ 16.3 $ 11.9 $ 1.9 $ 1.4 758%
Other $ 0.7 $ 0.5 $ 0.6 $ 0.4 17%
Less: Excise
Taxes $(21.6) $(15.7) $(24.1) $(17.7) -10%
Net Sales $ 64.1 $ 46.5 $ 49.8 $ 36.5 29%
(millions except
% metrics) Nine Months Ended September 30,
---------------------------------
2025 2024
--------------- ---------------
Change of
CAD $ USD $ CAD $ USD $ C $
------ ------ ------ ------ ----------
Retail Branded
Sales $166.3 $119.0 $195.9 $144.0 -15%
Non-Branded Sales $ 28.8 $ 20.7 $ 30.1 $ 22.1 -4%
International
Sales $ 40.6 $ 29.2 $ 6.0 $ 4.4 577%
Other $ 2.0 $ 1.4 $ 1.8 $ 1.3 11%
Less: Excise
Taxes $(62.2) $(44.5) $(77.7) $(57.1) -20%
Net Sales $175.5 $125.8 $156.0 $114.7 13%
Presentation of Financial Results
The Company's financial statements for the three and nine months ended September 30, 2025, as well as the comparative periods for 2024, have been prepared and presented under United States Generally Accepted Accounting Principals ("GAAP").
RESULTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts,
and unless otherwise noted)
---------------------------------------------------------------
Three Months Ended Nine Months Ended
September 30, September 30,
------------------- --------------------
2025 2024 2025 2024
-------- -------- -------- ---------
Sales $ 66,741 $ 54,938 $166,320 $ 150,522
Cost of sales (34,803) (41,301) (97,860) (112,031)
Gross profit 31,938 13,637 68,460 38,491
Selling, general
and
administrative
expenses (15,599) (14,565) (45,629) (45,871)
Interest expense (646) (779) (2,162) (2,594)
Interest income 360 229 544 757
Foreign exchange
(loss) gain (238) 352 1,470 (929)
Other (loss)
income (282) 379 4,169 528
Goodwill and
intangible
asset
impairments -- -- -- (11,939)
Income (loss)
before taxes
and equity
method
investment
income 15,533 (747) 26,852 (21,557)
Provision for
income taxes (4,717) (94) (8,203) (674)
Equity method
investment
income, net of
tax -- -- -- --
Income (loss)
from continuing
operations 10,816 (841) 18,649 (22,231)
(Loss) Income
from
discontinued
operations, net
of tax (276) 91 11,015 (4,756)
Income (loss)
including
non-controlling
interests 10,540 (750) 29,664 (26,987)
Less: net
(income) loss
attributable to
non-controlling
interests, net
of tax (323) (70) 347 (234)
Net income
(loss)
attributable to
Village Farms
International,
Inc.
shareholders $ 10,217 $ (820) $ 30,011 $ (27,221)
Adjusted EBITDA
from continuing
operations $ 20,686 $ 4,675 $ 41,246 $ 8,505
Adjustments
attributable to
discontinued
operations (398) 627 (7,617) (3,171)
------- ------- ------- --------
Adjusted EBITDA
(1) $ 20,288 $ 5,302 $ 33,629 $ 5,334
======= ======= ======= ========
Basic income
(loss) per share
attributable to
Village Farms
International,
Inc.
shareholders
from: $ -- $ -- $ -- $ --
Continuing
operations $ 0.09 $ (0.01) $ 0.17 $ (0.21)
Discontinued
operations (0.00) 0.00 0.10 (0.04)
------- ------- ------- --------
Basic income
(loss) per
share
attributable to
Village Farms
International,
Inc.
shareholders $ 0.09 $ (0.01) $ 0.27 $ (0.25)
======= ======= ======= ========
Diluted income
(loss) per share
attributable to
Village Farms
International,
Inc.
shareholders
from: $ -- $ -- $ -- $ --
Continuing
operations $ 0.08 $ (0.01) $ 0.16 $ (0.21)
Discontinued
operations $ -- $ -- $ 0.10 $ (0.04)
------- ------- ------- --------
Diluted income
(loss) per
share
attributable to
Village Farms
International,
Inc.
shareholders $ 0.08 $ (0.01) $ 0.26 $ (0.25)
======= ======= ======= ========
(1) Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA may not be comparable to similar measures presented by other issuers. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company because it excludes non-recurring and other items that do not reflect our business performance. Adjusted EBITDA includes the Company's 70% interest in Rose LifeScience through March 31, 2024, 80% interest in Rose LifeScience beginning on April 1, 2024, 85% interest in Leli through September 22, 2024, and our 100% interest in Leli beginning on September 23, 2024.
We caution that our results of operations for the three months and nine months ended September 30, 2025, and 2024 may not be indicative of our future performance.
SEGMENTED RESULTS OF OPERATIONS
(In thousands of U.S. dollars, except per share amounts,
and unless otherwise noted)
--------------------------------------------------------------------------------------------------------
For The Three Months Ended September 30, 2025
-----------------------------------------------------------------------------------
VF Fresh Cannabis Cannabis Clean Cannabis
(Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- --------- ------ ------------ ----------- ---------
Sales $ 12,841 $ 46,583 $ 3,337 $ 393 $ 3,587 $ -- $ 66,741
Cost of sales (10,833) (20,628) (1,348) (66) (1,928) -- (34,803)
Selling, general
and
administrative
expenses (217) (9,140) (2,425) (22) (702) (3,093) (15,599)
Other (expense)
income, net (465) (328) (3) -- (44) 34 (806)
Income (loss)
before taxes
and equity
method
investment
income 1,326 16,487 (439) 305 913 (3,059) 15,533
Provision for
income taxes (26) (4,486) -- (82) (123) -- (4,717)
Equity method
investment
income, net of
tax -- -- -- -- -- -- --
Income (loss)
from continuing
operations 1,300 12,001 (439) 223 790 (3,059) 10,816
Loss from
discontinued
operations net
of tax (276) -- -- -- -- -- (276)
Income (loss)
including
non-controlling
interests 1,024 12,001 (439) 223 790 (3,059) 10,540
Less: net income
attributable to
non-controlling
interests, net
of tax -- (323) -- -- -- -- (323)
Net income
(loss) $ 1,024 $ 11,678 $ (439) $ 223 $ 790 $ (3,059) $ 10,217
Adjusted EBITDA
from continuing
operations $ 2,479 $ 19,310 $ (332) $ 305 $ 1,265 $ (2,341) $ 20,686
Adjustments
attributable to
discontinued
operations (398) - - - - - (398)
-------- -------- -------- ----- ----------- ------- --------
Adjusted EBITDA
(1) $ 2,081 $ 19,310 $ (332) $ 305 $ 1,265 $ (2,341) $ 20,288
======== ======== ======== ===== =========== ======= ========
Basic income
(loss) per
share from
continuing
operations $ 0.01 $ 0.10 $ - $ - $ 0.01 $ (0.03) $ 0.09
Basic income per
share from
discontinued
operations $ - $ - $ - $ - $ - $ - $ -
-------- -------- -------- ----- ----------- ------- --------
Basic income
(loss) per
share $ 0.01 $ 0.10 $ - $ - $ 0.01 $ (0.03) $ 0.09
======== ======== ======== ===== =========== ======= ========
Diluted income
(loss) per
share from
continuing
operations $ 0.01 $ 0.10 $ - $ - $ 0.01 $ (0.03) $ 0.09
Diluted income
per share from
discontinued
operations $ - $ - $ - $ - $ - $ - $ -
-------- -------- -------- ----- ----------- ------- --------
Diluted income
(loss) per
share $ 0.01 $ 0.10 $ - $ - $ 0.01 $ (0.03) $ 0.09
======== ======== ======== ===== =========== ======= ========
For The Three Months Ended September 30, 2024
-----------------------------------------------------------------------------------
VF Fresh Cannabis Cannabis Clean Cannabis
(Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- --------- ------ ------------ ----------- ---------
Sales $ 14,340 $ 36,463 $ 3,943 $ 192 $ -- $ -- $ 54,938
Cost of sales (12,930) (26,864) (1,443) (64) -- -- (41,301)
Selling, general
and
administrative
expenses (715) (7,983) (2,692) (1) (385) (2,789) (14,565)
Other expense,
net (383) (16) -- 170 -- 410 181
Goodwill and
intangible asset
impairments -- -- -- -- -- -- --
Income (loss)
before taxes
and equity
method
investment
income 312 1,600 (192) 297 (385) (2,379) (747)
(Provision for)
recovery of
income taxes (27) (308) -- -- 239 2 (94)
Equity method
investment
income, net of
tax -- -- -- -- -- -- --
Income (loss)
from continuing
operations 285 1,292 (192) 297 (146) (2,377) (841)
Income from
discontinued
operations net
of tax 91 -- -- -- -- -- 91
Income (loss)
including
non-controlling
interests 376 1,292 (192) 297 (146) (2,377) (750)
Less: net
(income) loss
attributable to
non-controlling
interests, net
of tax -- (124) -- -- 54 -- (70)
Net income
(loss) $ 376 $ 1,168 $ (192) $ 297 $ (92) $ (2,377) $ (820)
Adjusted EBITDA
from continuing
operations $ 1,704 $ 4,752 $ (159) $ 313 $ (54) $ (1,881) $ 4,675
Adjustments
attributable to
discontinued
operations 627 - - - - - 627
-------- -------- -------- ----- ----------- ------- --------
Adjusted EBITDA
(1) $ 2,331 $ 4,752 $ (159) $ 313 $ (54) $ (1,881) $ 5,302
======== ======== ======== ===== =========== ======= ========
Basic income
(loss) per
share from
continuing
operations $ - $ 0.01 $ - $ - $ - $ (0.02) $ (0.01)
Basic income per
share from
discontinued
operations $ - $ - $ - $ - $ - $ - $ -
-------- -------- -------- ----- ----------- ------- --------
Basic income
(loss) per
share $ - $ 0.01 $ - $ - $ - $ (0.02) $ (0.01)
======== ======== ======== ===== =========== ======= ========
Diluted income
(loss) per
share from
continuing
operations $ - $ 0.01 $ - $ - $ - $ (0.02) $ (0.01)
Diluted income
per share from
discontinued
operations $ - $ - $ - $ - $ - $ - $ -
-------- -------- -------- ----- ----------- ------- --------
Diluted income
(loss) per
share $ - $ 0.01 $ - $ - $ - $ (0.02) $ (0.01)
======== ======== ======== ===== =========== ======= ========
For The Nine Months Ended September 30, 2025
-----------------------------------------------------------------------------------
VF Fresh Cannabis Cannabis Clean Cannabis
(Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- --------- ------ ------------ ----------- ---------
Sales $ 21,442 $ 125,938 $ 11,082 $1,302 $ 6,556 $ -- $ 166,320
Cost of sales (20,277) (70,040) (4,064) (219) (3,260) -- (97,860)
Selling, general
and
administrative
expenses (1,802) (26,506) (7,405) (23) (1,698) (8,195) (45,629)
Other income
(expense), net 3,478 (820) (220) -- (44) 1,627 4,021
Income (loss)
before taxes
and equity
method
investment
income 2,841 28,572 (607) 1,060 1,554 (6,568) 26,852
Provision for
income taxes (26) (7,720) -- (286) (171) -- (8,203)
Equity method
investment
income, net of
tax -- -- -- -- -- -- --
Income (loss)
from continuing
operations 2,815 20,852 (607) 774 1,383 (6,568) 18,649
Income from
discontinued
operations net
of tax 11,015 -- -- -- -- -- 11,015
Income (loss)
including
non-controlling
interests 13,830 20,852 (607) 774 1,383 (6,568) 29,664
Less: net loss
attributable to
non-controlling
interests, net
of tax -- 347 -- -- -- -- 347
Net income
(loss) $ 13,830 $ 21,199 $ (607) $ 774 $ 1,383 $ (6,568) $ 30,011
Adjusted EBITDA
from continuing
operations $ 7,128 $ 37,868 $ (173) $1,060 $ 2,560 $ (7,197) $ 41,246
Adjustments
attributable to
discontinued
operations (7,617) - - - - - (7,617)
-------- -------- -------- ----- ----------- ------- --------
Adjusted EBITDA
(1) $ (489) $ 37,868 $ (173) $1,060 $ 2,560 $ (7,197) $ 33,629
======== ======== ======== ===== =========== ======= ========
Basic income
(loss) per
share from
continuing
operations $ 0.02 $ 0.19 $ (0.01) $ 0.02 $ 0.01 $ (0.06) $ 0.17
Basic income per
share from
discontinued
operations $ 0.10 $ - $ - $ - $ - $ - $ 0.10
-------- -------- -------- ----- ----------- ------- --------
Basic income
(loss) per
share $ 0.12 $ 0.19 $ (0.01) $ 0.02 $ 0.01 $ (0.06) $ 0.27
======== ======== ======== ===== =========== ======= ========
Diluted income
(loss) per
share from
continuing
operations $ 0.02 $ 0.18 $ (0.01) $ 0.02 $ 0.01 $ (0.06) $ 0.16
Diluted income
per share from
discontinued
operations $ 0.10 $ - $ - $ - $ - $ - $ 0.10
-------- -------- -------- ----- ----------- ------- --------
Diluted income
(loss) per
share $ 0.12 $ 0.18 $ (0.01) $ 0.02 $ 0.01 $ (0.06) $ 0.26
======== ======== ======== ===== =========== ======= ========
For The Nine Months Ended September 30, 2024
-----------------------------------------------------------------------------------
VF Fresh Cannabis Cannabis Clean Cannabis
(Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- --------- ------ ------------ ----------- ---------
Sales $ 22,778 $ 114,654 $ 12,777 $ 313 $ -- $ -- $ 150,522
Cost of sales (22,129) (84,842) (4,953) (107) -- -- (112,031)
Selling, general
and
administrative
expenses (2,274) (24,436) (9,058) (38) (1,089) (8,976) (45,871)
Other expense
(income), net (1,406) (687) -- 170 -- (315) (2,238)
Goodwill and
intangible
asset
impairments -- -- (11,939) -- -- -- (11,939)
(Loss) income
before taxes
and equity
method
investment
income (3,031) 4,689 (13,173) 338 (1,089) (9,291) (21,557)
(Provision for)
recovery of
income taxes (23) (896) -- -- 239 6 (674)
Equity method
investment
income, net of
tax -- -- -- -- -- -- --
(Loss) income
from continuing
operations (3,054) 3,793 (13,173) 338 (850) (9,285) (22,231)
Loss from
discontinued
operations net
of tax (4,756) -- -- -- -- -- (4,756)
(Loss) income
including
non-controlling
interests (7,810) 3,793 (13,173) 338 (850) (9,285) (26,987)
Less: net
(income) loss
attributable to
non-controlling
interests, net
of tax -- (394) -- -- 160 -- (234)
Net (loss)
income $ (7,810) $ 3,399 $ (13,173) $ 338 $ (690) $ (9,285) $ (27,221)
Adjusted EBITDA
from continuing
operations $ 1,180 $ 13,643 $ (1,014) $ 354 $ (119) $ (5,539) $ 8,505
Adjustments
attributable to
discontinued
operations (3,171) - - - - - (3,171)
-------- -------- -------- ----- ----------- ------- --------
Adjusted EBITDA
(1) $ (1,991) $ 13,643 $ (1,014) $ 354 $ (119) $ (5,539) $ 5,334
======== ======== ======== ===== =========== ======= ========
Basic (loss)
income per
share from
continuing
operations $ (0.03) $ 0.03 $ (0.12) $ - $ (0.01) $ (0.08) $ (0.21)
Basic loss per
share from
discontinued
operations $ (0.04) $ - $ - $ - $ - $ - $ (0.04)
-------- -------- -------- ----- ----------- ------- --------
Basic (loss)
income per
share $ (0.07) $ 0.03 $ (0.12) $ - $ (0.01) $ (0.08) $ (0.25)
======== ======== ======== ===== =========== ======= ========
Diluted (loss)
income per
share from
continuing
operations $ (0.03) $ 0.03 $ (0.12) $ - $ (0.01) $ (0.08) $ (0.21)
Diluted loss per
share from
discontinued
operations $ (0.04) $ - $ - $ - $ - $ - $ (0.04)
-------- -------- -------- ----- ----------- ------- --------
Diluted (loss)
income per
share $ (0.07) $ 0.03 $ (0.12) $ - $ (0.01) $ (0.08) $ (0.25)
======== ======== ======== ===== =========== ======= ========
(1) Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA presented for these segments may not be comparable to similar measures presented by other issuers. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company because it excludes non-recurring and other items that do not reflect the underlying business performance of the Company.
This press release is intended to be read in conjunction with the Company's Consolidated Financial Statements ("Financial Statements") and Management's Discussion & Analysis ("MD&A") for the three and nine months ended September 30, 2025 in the Company Form 10-Q, which will be filed on (www.sec.gov/edgar.shtml) and SEDAR (www.sedar.com) and will be available at www.villagefarms.com.
Reconciliation of Net Income (Loss) to Adjusted EBITDA
The following tables reflect a reconciliation of net
income to Adjusted EBITDA, as presented by the Company:
For The Three Months Ended September 30, 2025
--------------------------------------------------------------------------------
(in thousands of VF Fresh Cannabis Cannabis Clean Cannabis
U.S. dollars) (Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- -------- ------ ------------ ----------- --------
Net income (loss)
from continuing
operations $ 1,300 $ 11,678 $ (439) $ 223 $ 790 $ (3,059) $ 10,493
Add: -- -- -- -- -- -- --
Amortization and
depreciation 813 2,928 47 -- 349 25 4,162
Foreign currency
exchange (gain)
loss (12) 19 -- -- -- 217 224
Interest
expense, net 345 192 -- -- -- (251) 286
Provision for
income taxes 26 4,486 -- 82 123 -- 4,717
Share-based
compensation 7 217 60 -- 3 727 1,014
Deferred
financing fees -- 32 -- -- -- -- 32
Adjustments
attributable to
non-controlling
interest -- (242) -- -- -- -- (242)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA
from continuing
operations 2,479 19,310 (332) 305 1,265 (2,341) 20,686
Adjustments
attributable to
discontinued
operations (398) -- -- -- -- -- (398)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA (2) $ 2,081 $ 19,310 $ (332) $ 305 $ 1,265 $ (2,341) $ 20,288
======== ======== ======= ===== =========== ======= =======
For The Three Months Ended September 30, 2024
--------------------------------------------------------------------------------
(in thousands of VF Fresh Cannabis Cannabis Clean Cannabis
U.S. dollars) (Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- -------- ------ ------------ ----------- --------
Net income (loss)
from continuing
operations $ 285 $ 1,168 $ (192) $ 297 $ (92) $ (2,377) $ (911)
Add: -- -- -- -- -- -- --
Amortization and
depreciation 817 3,341 50 -- 324 46 4,578
Foreign currency
exchange loss
(gain) 20 (28) -- -- -- (350) (358)
Interest
expense, net 555 42 -- 16 -- (63) 550
Provision for
(recovery of)
income taxes 27 308 -- -- (241) -- 94
Share-based
compensation -- 29 (17) -- -- 863 875
Adjustments
attributable to
non-controlling
interest -- (108) -- -- (45) -- (153)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA
from continuing
operations 1,704 4,752 (159) 313 (54) (1,881) 4,675
Adjustments
attributable to
discontinued
operations 627 -- -- -- -- -- 627
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA (2) $ 2,331 $ 4,752 $ (159) $ 313 $ (54) $ (1,881) $ 5,302
======== ======== ======= ===== =========== ======= =======
For The Nine Months Ended September 30, 2025
--------------------------------------------------------------------------------
(in thousands of VF Fresh Cannabis Cannabis Clean Cannabis
U.S. dollars) (Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- -------- ------ ------------ ----------- --------
Net income (loss)
from continuing
operations $ 2,815 $ 21,199 $ (607) $ 774 $ 1,383 $ (6,568) $ 18,996
Add: -- -- -- -- -- -- --
Amortization and
depreciation 3,086 8,231 145 -- 1,003 107 12,572
Foreign currency
exchange gain (94) (116) -- -- -- (1,327) (1,537)
Interest
expense, net 1,269 649 -- -- -- (300) 1,618
Provision for
income taxes 26 7,720 -- 286 171 -- 8,203
Share-based
compensation 26 290 72 -- 3 891 1,282
Deferred
financing fees -- 79 -- -- -- -- 79
Other
impairments -- -- 217 -- -- -- 217
Adjustments
attributable to
non-controlling
interest -- (184) -- -- -- -- (184)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA
from continuing
operations 7,128 37,868 (173) 1,060 2,560 (7,197) 41,246
Adjustments
attributable to
discontinued
operations (7,617) -- -- -- -- -- (7,617)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA (2) $ (489) $ 37,868 $ (173) $1,060 $ 2,560 $ (7,197) $ 33,629
======== ======== ======= ===== =========== ======= =======
For The Nine Months Ended September 30, 2024
--------------------------------------------------------------------------------
(in thousands of VF Fresh Cannabis Cannabis Clean Cannabis
U.S. dollars) (Produce) Canada U.S. Energy Netherlands Corporate Total
--------- --------- -------- ------ ------------ ----------- --------
Net income (loss)
from continuing
operations $ (3,054) $ 3,399 $(13,173) $ 338 $ (690) $ (9,285) $(22,465)
Add: -- -- -- -- -- -- --
Amortization and
depreciation 2,456 9,221 154 -- 951 152 12,934
Foreign currency
exchange loss
(gain) 58 (6) -- -- -- 714 766
Interest
expense, net 1,697 524 -- 16 -- (400) 1,837
Provision for
(recovery of)
income taxes 23 896 -- -- (241) (4) 674
Share-based
compensation -- 126 66 -- -- 3,284 3,476
Deferred
financing fees -- 10 -- -- -- -- 10
Goodwill and
intangible
impairments
(1) -- -- 11,939 -- -- -- 11,939
Adjustments
attributable to
non-controlling
interest -- (527) -- -- (139) -- (666)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA
from continuing
operations 1,180 13,643 (1,014) 354 (119) (5,539) 8,505
Adjustments
attributable to
discontinued
operations (3,171) -- -- -- -- -- (3,171)
-------- -------- ------- ----- ----------- ------- -------
Adjusted EBITDA (2) $ (1,991) $ 13,643 $ (1,014) $ 354 $ (119) $ (5,539) $ 5,334
======== ======== ======= ===== =========== ======= =======
(1) Reflects impairment to goodwill and intangibles of $11,939 in U.S. Cannabis that was based on recent historical performance, near-term forecasts, and the state of the CBD industry in the United States. See "Critical Accounting Estimates and Judgments" below for more information.
(2) Adjusted EBITDA is not a recognized earnings measure and does not have a standardized meaning prescribed by GAAP. Therefore, Adjusted EBITDA presented for these segments may not be comparable to similar measures presented by other issuers. Management believes that Adjusted EBITDA is a useful supplemental measure in evaluating the performance of the Company because it excludes non-recurring and other items that do not reflect the underlying business performance of the Company.
A detailed discussion of our consolidated and segment results can be found in the 10-Q MD&A on the Village Farms website under Financial Reports within the Investors section.
Cautionary Statement Regarding Forward-Looking Information
As used in this Press Release, the terms "Village Farms", "Village Farms International", the "Company", "we", "us", "our" and similar references refer to Village Farms International, Inc. and our consolidated subsidiaries, and the term "Common Shares" refers to our common shares, no par value. Our financial information is presented in U.S. dollars and all references in this Press Release to "$" means U.S. dollars and all references to "C$" means Canadian dollars.
This Press Release contains forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995, Section 27A of the U.S. Securities Act of 1933, as amended, (the "Securities Act") and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and is subject to the safe harbor created by those sections. This Press Release also contains "forward-looking information" within the meaning of applicable Canadian securities laws. We refer to such forward-looking statements and forward-looking information collectively as "forward-looking statements". Forward-looking statements may relate to the Company's future outlook or financial position and anticipated events or results and may include statements regarding the financial position, business strategy, budgets, expansion plans, litigation, projected production, projected costs, capital expenditures, financial results, tariffs, taxes, plans and objectives of or involving the Company or statements regarding the anticipated benefits from the closing of the transaction involving Vanguard Food LP. Particularly, statements regarding future results, performance, achievements, prospects or opportunities for the Company, the greenhouse vegetable or produce industry, the cannabis industry and market and our energy segment are forward-looking statements. In some cases, forward-looking information can be identified by such terms as "can", "outlook", "may", "might", "will", "could", "should", "would", "occur", "expect", "plan", "anticipate", "believe", "intend", "try", "estimate", "predict", "potential", "continue", "likely", "schedule", "objectives", or the negative or grammatical variation thereof or other similar expressions concerning matters that are not historical facts. The forward-looking statements in this Press Release are subject to risks that may include, but are not limited to: our limited operating history in the cannabis and cannabinoids industry, including that of Pure Sunfarms, Corp. ("Pure Sunfarms"), Rose LifeScience Inc. ("Rose" or "Rose LifeScience") and Balanced Health Botanicals, LLC ("Balanced Health"); the limited operational history of the Delta RNG Project in our energy segment and Leli Holland B.V. ("Leli"); the legal status of the cannabis business of Pure Sunfarms and Rose and the hemp business of Balanced Health and uncertainty regarding the legality and regulatory status of cannabis in the United States; risks relating to the integration of Balanced Health and Rose into our consolidated business; risks relating to obtaining additional financing on acceptable terms, including our dependence upon credit facilities and dilutive transactions; potential difficulties in achieving and/or maintaining profitability; variability of product pricing; risks inherent in the cannabis, hemp, CBD, cannabinoids, and agricultural businesses; our market position and competitive position; our ability to leverage current business relationships for future business involving hemp and cannabinoids; the ability of Pure Sunfarms and Rose to cultivate and distribute cannabis in Canada as well as exports; risks related to the start-up of international production at our Netherlands operations under Leli; existing and new governmental regulations, including risks related to regulatory compliance and regarding obtaining and maintaining licenses required under the Cannabis Act (Canada), the Criminal Code and other Acts, S.C. 2018, C. 16 (Canada) for its Canadian operational facilities, and changes in our regulatory requirements; legal and operational risks relating to expected conversion of our greenhouses to cannabis production in Canada and in the United States; risks related to rules and regulations at the U.S. Federal (Food and Drug Administration and United States Department of Agriculture), state and municipal levels with respect to produce and hemp, cannabidiol-based products commercialization; retail consolidation, technological advances and other forms of competition; transportation disruptions; product liability and other potential litigation; retention of key executives; labor issues; uninsured and underinsured losses; vulnerability to rising energy costs; inflationary effects on costs of cultivation and transportation; recessionary effects on demand of our products; environmental, health and safety risks, foreign exchange exposure, risks associated with cross-border trade and the potential for tariffs and other trade restrictions; difficulties in managing our growth; restrictive covenants under our credit facilities; natural catastrophes; elevated interest rates; and tax risks.
The Company has based these forward-looking statements on factors and assumptions about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. Although the forward-looking statements contained in this Press Release are based upon assumptions that management believes are reasonable based on information currently available to management, there can be no assurance that actual results will be consistent with these forward-looking statements. Forward-looking statements necessarily involve known and unknown risks and uncertainties, many of which are beyond the Company's control, which may cause the Company's or the industry's actual results, performance, achievements, prospects and opportunities in future periods to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, among other things, the factors contained in the Company's filings with securities regulators, including this Press Release and the Company's most recently filed annual report on Form 10-K.
When relying on forward-looking statements to make decisions, the Company cautions readers not to place undue reliance on these statements, as forward-looking statements involve significant risks and uncertainties and should not be read as guarantees of future results, performance, achievements, prospects and opportunities. The forward-looking statements made in this Press Release relate only to events or information as of the date on which the statements are made in this Press Release. Except as required by law, the Company undertakes no obligation to update or revise publicly any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events.
Village Farms International, Inc.
Condensed Consolidated Statements of Financial Position
(In thousands of United States dollars, except share
data)
(Unaudited)
September 30, 2025 December 31, 2024
-------------------- ---------------------
ASSETS
Current assets
Cash and cash
equivalents $ 82,561 $ 24,631
Restricted cash 5,000 --
Trade receivables, net 31,351 22,160
Inventories, net 34,203 41,256
Other receivables 579 247
Prepaid expenses and
deposits 2,931 2,806
Current assets of
discontinued
operations -- 24,919
--------------- --------------
Total current assets 156,625 116,019
--------------- --------------
Non-current assets
Property, plant and
equipment, net 179,845 175,226
Investments 6,279 2,656
Goodwill 43,696 42,315
Intangibles, net 23,755 25,105
Deferred tax asset 719 1,005
Right-of-use assets 3,587 4,372
Other assets 3,878 2,178
Non-current assets of
discontinued
operations -- 20,430
Total assets $ 418,384 $ 389,306
=============== ==============
LIABILITIES
Current liabilities
Line of credit $ -- $ 4,000
Trade payables 9,511 11,254
Current maturities of
long-term debt 4,841 8,142
Accrued sales taxes 11,758 8,740
Accrued loyalty program 519 1,029
Accrued liabilities 10,116 8,972
Lease liabilities -
current 1,134 1,060
Income tax payable 8,538 51
Other current
liabilities 7,381 1,053
Current liabilities of
discontinued
operations 2,608 17,918
--------------- --------------
Total current liabilities 56,406 62,219
--------------- --------------
Non-current liabilities
Long-term debt 29,753 32,420
Deferred tax liability 20,161 19,940
Lease liabilities -
non-current 3,459 4,199
Other non-current
liabilities 3,240 2,196
Non-current liabilities
of discontinued
operations -- 4,374
--------------- --------------
Total liabilities 113,019 125,348
--------------- --------------
MEZZANINE EQUITY
Redeemable
non-controlling
interest 9,997 9,953
SHAREHOLDERS' EQUITY
Common stock, no par
value per share -
unlimited shares
authorized;
114,970,100 shares
issued and
outstanding at
September 30, 2025
and 112,337,049
shares issued and
outstanding at
December 31, 2024. 390,893 387,349
Additional paid in
capital 31,886 30,604
Accumulated other
comprehensive loss (12,406) (18,932)
Retained earnings (115,005) (145,016)
--------------- --------------
Total shareholders'
equity 295,368 254,005
Total liabilities,
mezzanine equity and
shareholders' equity $ 418,384 $ 389,306
=============== ==============
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
Village Farms International, Inc.
Condensed Consolidated Statements of Operations and
Comprehensive Income (Loss)
(In thousands of United States dollars, except per
share data)
(Unaudited)
Three Months Ended Nine Months Ended
September 30, September 30,
-------------------- -----------------------
2025 2024 2025 2024
--------- --------- --------- ------------
Sales $ 66,741 $ 54,938 $166,320 $ 150,522
Cost of sales (34,803) (41,301) (97,860) (112,031)
------- ------- ------- --------
Gross profit 31,938 13,637 68,460 38,491
Selling, general and
administrative
expenses (15,599) (14,565) (45,629) (45,871)
Interest expense (646) (779) (2,162) (2,594)
Interest income 360 229 544 757
Foreign exchange
(loss) gain (238) 352 1,470 (929)
Other (loss) income (282) 379 4,169 528
Goodwill and
intangible asset
impairments -- -- -- (11,939)
------- ------- ------- --------
Income (loss) before
taxes and equity
method investment
income 15,533 (747) 26,852 (21,557)
Provision for income
taxes (4,717) (94) (8,203) (674)
Equity method
investment income,
net of tax -- -- -- --
------- ------- ------- --------
Income (loss) from
continuing
operations 10,816 (841) 18,649 (22,231)
(Loss) Income from
discontinued
operations, net of
tax (276) 91 11,015 (4,756)
------- ------- ------- --------
Income (loss)
including
non-controlling
interests 10,540 (750) 29,664 (26,987)
Less: net (income)
loss attributable to
non-controlling
interests, net of
tax (323) (70) 347 (234)
------- ------- ------- --------
Net income (loss)
attributable to
Village Farms
International, Inc.
shareholders $ 10,217 $ (820) $ 30,011 $ (27,221)
======= ======= ======= ========
Basic income (loss) per share
attributable to Village Farms
International, Inc. shareholders
from:
Continuing operations $ 0.09 $ (0.01) $ 0.17 $ (0.21)
Discontinued
operations - - 0.10 (0.04)
------- ------- ------- --------
Basic income (loss)
per share
attributable to
Village Farms
International, Inc.
shareholders $ 0.09 $ (0.01) $ 0.27 $ (0.25)
======= ======= ======= ========
Diluted income (loss) per share
attributable to Village Farms
International, Inc. shareholders
from:
Continuing operations $ 0.08 $ (0.01) $ 0.16 $ (0.21)
Discontinued
operations - - 0.10 (0.04)
------- ------- ------- --------
Diluted income (loss)
per share
attributable to
Village Farms
International, Inc.
shareholders $ 0.08 $ (0.01) $ 0.26 $ (0.25)
======= ======= ======= ========
Weighted average
number of common
shares used in the
computation of net
income (loss) per
share (in
thousands):
Basic 113,039 111,917 112,577 111,045
======= ======= ======= ========
Diluted 120,565 111,917 115,292 111,045
======= ======= ======= ========
Income (loss)
including
non-controlling
interests $ 10,540 $ (750) $ 29,664 $ (26,987)
Other comprehensive
income (loss):
Foreign currency
translation
adjustment (3,920) 2,595 6,915 (3,655)
------- --------
Comprehensive income
(loss) including
non-controlling
interests 6,620 1,845 36,579 (30,642)
------- ------- ------- --------
Comprehensive
(income) loss
attributable to
non-controlling
interests (140) (222) (40) 10
Comprehensive income
(loss) attributable
to Village Farms
International, Inc.
shareholders $ 6,480 $ 1,623 $ 36,539 $ (30,632)
======= ======= ======= ========
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
Village Farms International, Inc.
Condensed Consolidated Statements of Cash Flows
(In thousands of United States dollars)
(Unaudited)
Nine Months Ended September 30,
-----------------------------------------
2025 2024
------------------- --------------------
Cash flows provided by (used
in) operating activities:
Income (loss) from
continuing operations
including non-controlling
interests $ 18,649 $ (22,231)
Adjustments to reconcile
net loss attributable to
Village Farms
International, Inc.
shareholders to net cash
provided by (used in)
operating activities of
continuing operations:
Depreciation and
amortization 12,572 12,934
Amortization of deferred
charges 79 10
Interest expense 2,162 2,594
Interest paid on
long-term debt (2,215) (3,128)
Unrealized foreign
exchange (gain) loss (56) 143
Goodwill and intangible
asset impairments -- 11,939
Non-cash lease expense 740 593
Share-based compensation 1,282 3,476
Deferred income taxes (133) 384
Changes in non-cash
working capital items 13,630 (3,911)
----------- -------------
Net cash provided by
operating activities
from continuing
operations 46,710 2,803
----------- -------------
Cash flows used in investing
activities:
Purchases of property,
plant and equipment (7,117) (5,527)
Purchases of intangibles -- (80)
----------- -------------
Net cash used in
investing activities
from continuing
operations (7,117) (5,607)
----------- -------------
Cash flows (used in) provided
by financing activities:
Repayments on borrowings (6,612) (4,301)
Purchase of
non-controlling interest -- (3,817)
Proceeds from exercise of
warrants and options 3,544 --
Other financing activities (543) --
Net cash used in
financing activities
from continuing
operations (3,611) (8,118)
----------- -------------
Discontinued Operations
Net cash (used in)
provided by operating
activities from
discontinued operations (5,865) 7,139
Net cash provided by (used
in) investing activities
from discontinued
operations 38,710 (2,620)
Net cash used in financing
activities from
discontinued operations (4,000) --
Net cash flows provided
by discontinued
operations 28,845 4,519
----------- -------------
Effect of exchange rate changes
on cash and cash equivalents (1,897) (192)
----------- -------------
Net increase (decrease) in
cash, cash equivalents and
restricted cash 62,930 (6,595)
Cash, cash equivalents and
restricted cash, beginning of
period 24,631 35,291
Cash, cash equivalents and
restricted cash, end of
period $ 87,561 $ 28,696
=========== =============
The accompanying notes are an integral part of these Condensed Consolidated Financial Statements.
(END) Dow Jones Newswires
November 10, 2025 07:00 ET (12:00 GMT)